4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Analysis, modelling and sensing of both physiological and environmental factors for the customized and predictive self-management of Asthma (myAirCoach)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2017,
"myAirCoach aims to develop a holistic mHealth personalised asthma monitoring system empowering patients to manage their own health by providing user friendly tools to increase the awareness of their clinical state and effectiveness of medical treatment. This will be achieved through a multi-disciplinary approach aiming at the development of an ergonomic, compact and efficient sensor-based inhaler ...
Voir le projet
13
Participants partenaires
TERMINÉ
European Asthma Research and Innovation Partnership (EARIP)
Date du début: 1 sept. 2013, Date de fin: 31 août 2016,
Europe has 30 million people with asthma, whose treatment costs about €20 bn annually. Productivity lost through poor asthma control in Europe is estimated to be €9.8 bn per year. By 2020 approximately 120,000 people in Europe will die from asthma attacks, and 4 million hospitalisations will be needed for the most severely affected.The Objectives of EARIP (European Asthma Research and Innovation P ...
Voir le projet
14
Participants partenaires
TERMINÉ
Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling (AirPROM)
Date du début: 1 mars 2011, Date de fin: 30 juin 2016,
The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million people world-wide and cause considerable morbidity and mortality. Airways disease costs the European Union in excess of €56 billion per annum. Current therapies are inadequate and we do not have sufficient tools to predict disease progression or response to current or future therapies. Our consortium, Air ...
Voir le projet
40
Participants partenaires
TERMINÉ
Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED)
Date du début: 1 oct. 2009, Date de fin: 30 sept. 2015,
RationaleThe inability of pre-clinical studies to predict clinical efficacy is a major bottleneck in drug development. In severe asthma this bottleneck results from: a lack of useful and validated biomarkers, underperforming pre-clinical models, inadequate and incomplete sub-phenotyping, and insufficient disease understanding.HypothesisThe use of biomarker profiles comprised of various types of hi ...
Voir le projet